Days after the Barwani eye camp incident where 45 people lost their sight, the Madhya Pradesh health department banned on Tuesday 19 drugs that are unsafe and of sub-standard quality.
The banned drugs from different pharmaceuticals were being supplied to several government hospitals and primary health centres in the state.
An order of the Madhya Pradesh Public Health Services Corporation (MPPSHSC) said the drugs were stocked in government hospitals of the state and were about to expire next year but they were unsafe and of sub-standard quality.
Chief medical health officers and civil surgeons have been asked to strictly seal the existing stock and refrain from prescribing these drugs to patients and storekeepers.
“We received a letter from Dr Vinay Kumar Dubey who is the general manager of (MPPHSC), accompanied with a list of the entire 19 drugs which have to be banned by us,” said Dr Sharad Pandit, joint director of health, Indore division.
A series of drugs by pharmaceuticals from across the country are mentioned in the list, including four from Dhar-based Beryl Drugs Ltd, whose saline has been held responsible by most of the investigating agencies in the Barwani case.
Other companies that have more than one drug listed are Care group, Vadodara; Jawa Pharmaceuticals, Jaipur and Amanta Health care Ltd.
Questioning the entire credibility of the company from wherein these drugs were procured through a tender and supplied to government hospitals. The list is indicative of the a loophole in the entire system of drug purchase in the state.
“The letter which has been sent to us clearly mentions that these drugs will not be supplied till notified by the department,” added Dr Pandit.
List of banned firms
Ploymer technologies, Vadodara
Cipla, Ltd, Haridwar
Care group, Vadodara
Care group Vadodara
Sunways India, Ahemdabad
Jawa Pharmaceuticals, Jaipur
Beryl Drugs Ltd, Dhar
IVES Drugs India Pvt Ltd, Dhar
Amanta Healthcare, Ltd Gujarat
Shreya Life science, Aurangabad
Nandani Medical laboratories, Indore
FDC ltd, Aurangabad